These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 18273859

  • 1. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
    Popławska-Kita A, Mierzejewska-Iwanowska B, Szelachowska M, Siewko K, Nikołajuk A, Kinalska I, Górska M.
    Diabetes Metab Res Rev; 2008; 24(4):310-7. PubMed ID: 18273859
    [Abstract] [Full Text] [Related]

  • 2. Diabetic microangiopathy and urinary glycosaminoglycans.
    Kahaly G, Hansen C, Otto E, Förster G, Beyer J, Hommel G.
    Exp Clin Endocrinol Diabetes; 1997; 105(3):145-51. PubMed ID: 9228510
    [Abstract] [Full Text] [Related]

  • 3. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
    De Muro P, Fresu P, Formato M, Tonolo G, Mameli M, Maioli M, Sanna GM, Cherchi GM.
    J Nephrol; 2002; 15(3):290-6. PubMed ID: 12113601
    [Abstract] [Full Text] [Related]

  • 4. Insulin-dependent diabetes mellitus and glycosaminoglycans.
    Hansen C, Irmscher AK, Kuhlemann K, Beyer J, Kahaly G.
    Horm Metab Res; 1995 Dec; 27(12):555-8. PubMed ID: 8750785
    [Abstract] [Full Text] [Related]

  • 5. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura.
    McAuliffe AV, Fisher EJ, McLennan SV, Yue DK, Turtle JR.
    Diabet Med; 1996 Aug; 13(8):758-63. PubMed ID: 8862953
    [Abstract] [Full Text] [Related]

  • 6. Glycosaminoglycans in urine of type 1 diabetic patients.
    Sindelka G, Skrha J, Stibor V, Stolba P.
    Sb Lek; 1993 Aug; 94(1):77-80. PubMed ID: 7992002
    [Abstract] [Full Text] [Related]

  • 7. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
    Navarro JF, Mora C, Muros M, García J.
    Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
    [Abstract] [Full Text] [Related]

  • 8. Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy.
    Hinokio Y, Suzuki S, Hirai M, Suzuki C, Suzuki M, Toyota T.
    Diabetologia; 2002 Jun; 45(6):877-82. PubMed ID: 12107732
    [Abstract] [Full Text] [Related]

  • 9. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW, Kim HJ, Bae JS, Jeong GH, Chung SC, Kim JG, Park SH, Kim YL, Kam S, Kim IS, Kim BW.
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [Abstract] [Full Text] [Related]

  • 10. Urinary type IV collagen: a specific indicator of incipient diabetic nephropathy.
    Tan Y, Yang Y, Zhang Z, Zhang X, Zhang Z, Liu Y.
    Chin Med J (Engl); 2002 Mar; 115(3):389-94. PubMed ID: 11940372
    [Abstract] [Full Text] [Related]

  • 11. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases.
    Tencer J, Torffvit O, Björnsson S, Thysell H, Grubb A, Rippe B.
    Clin Nephrol; 1997 Oct; 48(4):212-9. PubMed ID: 9352154
    [Abstract] [Full Text] [Related]

  • 12. Urinary type IV collagen levels in diabetes mellitus.
    Sthaneshwar P, Chan SP.
    Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
    [Abstract] [Full Text] [Related]

  • 13. Comparison of urinary excretion of albumin, alpha 1-microglobulin and retinol-binding protein in diabetic patients.
    Galanti LM, Jamart J, Dell'omo J, Donckier J.
    Diabetes Metab; 1996 Oct; 22(5):324-30. PubMed ID: 8896994
    [Abstract] [Full Text] [Related]

  • 14. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y.
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [Abstract] [Full Text] [Related]

  • 15. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
    Piwowar A, Knapik-Kordecka M, Fus I, Warwas M.
    Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
    [Abstract] [Full Text] [Related]

  • 16. [Diabetic nephropathy].
    Agardh CD.
    Nord Med; 1992 May; 107(8-9):215-6. PubMed ID: 1408727
    [Abstract] [Full Text] [Related]

  • 17. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
    Meier M, Kaiser T, Herrmann A, Knueppel S, Hillmann M, Koester P, Danne T, Haller H, Fliser D, Mischak H.
    J Diabetes Complications; 2005 May; 19(4):223-32. PubMed ID: 15993357
    [Abstract] [Full Text] [Related]

  • 18. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H.
    J Diabetes Complications; 2008 May; 22(6):384-8. PubMed ID: 18413152
    [Abstract] [Full Text] [Related]

  • 19. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis].
    Shestakova MV, Koshel' LV, Vagodin VA, Dedov II.
    Ter Arkh; 2006 May; 78(5):60-4. PubMed ID: 16889052
    [Abstract] [Full Text] [Related]

  • 20. Urinary PC-1 activity in patients with type 1 diabetes mellitus.
    Stefanović V, Rajić M, Antić S, Mitić-Zlatković M, Stojiljković S, Ivić MA, Vlahović P.
    Ann Clin Biochem; 2003 May; 40(Pt 3):235-8. PubMed ID: 12803834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.